BackGRI Bio Overview

GRI Bio Accounts Payable

GRI Bio's accounts payable is $300K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$303000.00
77.74% YoYΔ $-1.06M vs prior year quarter

Peer trimmed avg / median

Loading

GRI Bio Accounts Payable History

Loading

GRI Bio vs. peers: Accounts Payable Comparison

Loading

GRI Bio Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GRI Bio (GRI) FAQ

As of the most recent data (April 2026), GRI shows a accounts payable of $300K. That compares with $1.4M in the prior-year period — down 77.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRI's accounts payable is now $300K (was $1.4M) — a 77.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GRI Bio is outperforming or lagging.

Tracking GRI's accounts payable over time shows whether GRI Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $300K That compares with $1.4M in the prior-year period — down 77.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has GRI Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $300K) with ownership activity and broader fundamentals.

GRI Bio's accounts payable is $300K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.